Variant report
Variant | nsv519254 |
---|---|
Chromosome Location | chr13:54414564-54442809 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:54411879..54413790-chr13:54440349..54442010,2 | K562 | blood: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OLFM4-10 | chr13:54424439-54424529 | l_854_chr13:54424438-54458818_testes |
2 | lnc-OLFM4-3 | chr13:54414818-54414945 | ENSG00000261517.1 |
3 | lnc-OLFM4-3 | chr13:54418480-54418657 | ENSG00000261517.1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574472652 | chr13:54414846-54414847 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs543437041 | chr13:54414854-54414855 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs541631859 | chr13:54414927-54414928 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs1379831 | chr13:54418506-54418507 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs560600540 | chr13:54418510-54418511 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs574058731 | chr13:54418546-54418547 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs572914534 | chr13:54418605-54418606 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs542626192 | chr13:54418624-54418625 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs564017742 | chr13:54418628-54418629 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs530674987 | chr13:54418636-54418637 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs550854591 | chr13:54418641-54418642 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs530379960 | chr13:54421603-54421604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs113338205 | chr13:54421615-54421616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189593548 | chr13:54421644-54421645 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs532609768 | chr13:54421648-54421649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114702964 | chr13:54421683-54421684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534102130 | chr13:54421724-54421725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs77363056 | chr13:54421736-54421737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565867059 | chr13:54421744-54421745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs550828602 | chr13:54421749-54421750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs564783541 | chr13:54421752-54421753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs142414237 | chr13:54421765-54421766 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532815483 | chr13:54421828-54421829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs9596858 | chr13:54421858-54421859 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs568364162 | chr13:54421896-54421897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182528369 | chr13:54421916-54421917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556223510 | chr13:54421954-54421955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs188235431 | chr13:54422004-54422005 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs538863772 | chr13:54422043-54422044 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs193001536 | chr13:54422057-54422058 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs572137173 | chr13:54422070-54422071 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs541137423 | chr13:54422095-54422096 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs532992206 | chr13:54422174-54422175 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs368346149 | chr13:54422180-54422181 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574398611 | chr13:54422200-54422201 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs17088978 | chr13:54422204-54422205 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs556122440 | chr13:54422206-54422207 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs535505229 | chr13:54422234-54422235 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs574199100 | chr13:54422239-54422240 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs549465369 | chr13:54422240-54422241 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs185204394 | chr13:54422282-54422283 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs35869865 | chr13:54422354-54422355 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs9568942 | chr13:54422355-54422356 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545951638 | chr13:54422384-54422385 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs200873479 | chr13:54422424-54422425 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559527252 | chr13:54422510-54422511 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528516148 | chr13:54422560-54422561 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs549205215 | chr13:54422585-54422586 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
49 | rs569047189 | chr13:54422611-54422612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570376511 | chr13:54422615-54422616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 19242612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Multiple myeloma | 19135901 | CNVD |
Autism | 18414403 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Prostate cancer | 16461572 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21858162 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 16272173 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20467480 | CNVD |
Gastric cancer | 17908304 | CNVD |
Breast cancer | 18852474 | CNVD |
Myelofibrosis | 22110671 | CNVD |
craniofacial dysmorphism | 21918468 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:54421600-54422000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
2 | chr13:54422000-54422400 | Active TSS | Pancreatic Islets | Pancreatic Islet |
3 | chr13:54422200-54423400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr13:54422200-54423800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
5 | chr13:54422200-54423800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr13:54422400-54422600 | Flanking Active TSS | Pancreatic Islets | Pancreatic Islet |
7 | chr13:54422400-54423000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr13:54422400-54423200 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
9 | chr13:54422400-54423200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr13:54422400-54423400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
11 | chr13:54422400-54423400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
12 | chr13:54422600-54423200 | Enhancers | H1 Cell Line | embryonic stem cell |
13 | chr13:54422600-54423200 | Enhancers | H9 Cell Line | embryonic stem cell |
14 | chr13:54422600-54423200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr13:54422600-54423400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
16 | chr13:54422600-54423600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
17 | chr13:54422800-54423000 | Bivalent Enhancer | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
18 | chr13:54429600-54430200 | Active TSS | Esophagus | oesophagus |
19 | chr13:54431400-54432400 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
20 | chr13:54432400-54433600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
21 | chr13:54433600-54433800 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
22 | chr13:54437000-54438000 | Enhancers | Fetal Brain Male | brain |
23 | chr13:54439800-54440800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
24 | chr13:54440800-54445200 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |